Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
1(8%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
8%
Ph phase_2
2
15%
Ph early_phase_1
1
8%
Ph not_applicable
8
62%

Phase Distribution

1

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution12 total trials
Early Phase 1First-in-human
1(8.3%)
Phase 2Efficacy & side effects
2(16.7%)
Phase 3Large-scale testing
1(8.3%)
N/ANon-phased studies
8(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

13

all time

Status Distribution
Active(1)
Completed(10)
Other(2)

Detailed Status

Completed10
unknown1
Suspended1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (8.3%)
Phase 22 (16.7%)
Phase 31 (8.3%)
N/A8 (66.7%)

Trials by Status

completed1077%
unknown18%
suspended18%
active_not_recruiting18%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
13